Susquehanna International Group, LLP Champions Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 126,530 shares of CSBR stock, worth $826,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,530
Previous 11,524
997.97%
Holding current value
$826,240
Previous $98,000
1020.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CSBR
# of Institutions
40Shares Held
5.93MCall Options Held
43.4KPut Options Held
2.1K-
Battery Management Corp. Boston, MA2.42MShares$15.8 Million3.06% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$11.2 Million1.41% of portfolio
-
Tocqueville Asset Management L.P. New York, NY400KShares$2.61 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA327KShares$2.14 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny152KShares$992,8140.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $88.3M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...